An MYC-Driven Vicious Circuit Is a Targetable Achilles' Heel in Lymphoma

被引：1
|
作者：
Wilson, Erica B. [1 ]
Klein, Ulf [1 ,2 ]
机构：
[1] Univ Leeds, Leeds Inst Med Res St Jamess, Leeds, England
[2] Univ Leeds, Leeds Inst Med Res St Jamess, Leeds LS9 7TF, England
来源：
BLOOD CANCER DISCOVERY | 2023年 / 4卷 / 04期
关键词：
D O I：
10.1158/2643-3230.BCD-23-0053
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
In this issue of Blood Cancer Discovery, Nakanishi et al. uncover a critical role for the elevated activity of the translation initiation factor eIF5A in the malignant growth of MYC-driven lymphoma. eIF5A is posttrans-lationally modifi ed by hypusination through MYC oncoprotein-mediated hyperactivation of the polyamine- hypusine circuit, which may represent a promising therapeutic target because an enzyme of this circuit that is required for hypusinating eIF5A proved to be essential for lymphoma development.
引用
收藏
页码：248 / 251
页数：4
相关论文
共 50 条
  • [1] The spliceosome, a potential Achilles heel of MYC-driven tumors
    Anczukow, Olga
    Krainer, Adrian R.
    GENOME MEDICINE, 2015, 7
  • [2] The spliceosome, a potential Achilles heel of MYC-driven tumors
    Olga Anczuków
    Adrian R. Krainer
    Genome Medicine, 7
  • [3] Targeting nucleotide synthesis in MYC-driven lymphoma
    Gemma K. Alderton
    Nature Reviews Cancer, 2014, 14 (7) : 452 - 452
  • [4] Targeting Oncoprotein Translation with Rocaglates in MYC-Driven Lymphoma
    Zhang, Xuan
    Bi, Chengfeng
    Lu, Ting
    Yue, Ting
    Zhang, Weiwei
    Zhang, Xiaoyan
    Cheng, Wang
    Tian, Tian
    Lunning, Matthew A.
    Vose, Julie M.
    Pelletier, Jerry
    Porco, John A., Jr.
    Tao, Jianguo
    Fu, Kai
    BLOOD, 2018, 132
  • [5] Synthetic lethal targeting of SUMOylation in Myc-driven lymphoma
    Hoellein, A.
    Fallahi, M.
    Schaub, F.
    Schoeffmann, S.
    Steidle, S.
    Rudelius, M.
    Miething, C.
    Peschel, C.
    Cleveland, J.
    Keller, U.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 11 - 11
  • [6] Scribble acts as an oncogene in Eμ-myc-driven lymphoma
    E D Hawkins
    J Oliaro
    K M Ramsbottom
    A Newbold
    P O Humbert
    R W Johnstone
    S M Russell
    Oncogene, 2016, 35 : 1193 - 1197
  • [7] Scribble acts as an oncogene in Eμ-myc-driven lymphoma
    Hawkins, E. D.
    Oliaro, J.
    Ramsbottom, K. M.
    Newbold, A.
    Humbert, P. O.
    Johnstone, R. W.
    Russell, S. M.
    ONCOGENE, 2016, 35 (09) : 1193 - 1197
  • [8] MYC Signatures and Characterization of MYC-Driven Aggressive B-Cell Lymphoma
    Xu-Monette, Zijun Y.
    Manyam, Ganiraju C.
    Tzankov, Alexander
    Deng, Qipan
    Visco, Carlo
    Tu, Meifeng
    Li, Ling
    Zu, Youli
    Dybkaer, Karen
    Chiu, April
    Orazi, Attilio
    Bhagat, Govind
    Richards, Kristy L.
    Hsi, Eric D.
    Choi, William W. L.
    van Krieken, J. Han
    Huh, Jooryung
    Ponzoni, Maurilio
    Ferreri, Andres J. M.
    Moller, Michael B.
    Farnen, John P.
    Zhao, Xiaoying
    Piris, Miguel A.
    Winter, Jane N.
    Miranda, Roberto N.
    McDonnell, Timothy J.
    Medeiros, L. Jeffrey
    Li, Yong
    Young, Ken H.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 : S223 - S223
  • [9] Targeting MYC-driven lymphoma: lessons learned and future directions
    Martinez-Martin, Sandra
    Beaulieu, Marie-Eve
    Soucek, Laura
    CANCER DRUG RESISTANCE, 2023, 6 (02) : 205 - 222
  • [10] BCR LOSS REDUCES THE FITNESS OF MYC-DRIVEN LYMPHOMA CELLS
    不详
    CANCER DISCOVERY, 2017, 7 (07) : 664 - 664
12345